Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: stroke; This is a spontaneous report downloaded from the Regulatory Authority-WEB: IT-MINISAL02- 692495. A contactable other healthcare professional (patient family member) reported that an 89-year-old female patient received first dose of BNT162B2 (COMIRNATY; Formulation: Solution for injection; Lot number: EP9598) via an unspecified route of administration on 26Feb2021 as a single dose for COVID-19 immunisation. Medical history included ongoing cardiac disorder. Concomitant medication included furosemide sodium (LASIX) and anticoagulant therapy (unspecified). On 27Feb2021, the patient experienced stroke. In the morning following the date of administration of the 1st dose (performed on 26Feb2021) the patient was found in a confessional state and motor alteration (left side of the body), hospitalized in the emergency room with a diagnosis of stroke by CT, subsequent aggravation and death in the afternoon of 04Mar2021. It was not reported if an autopsy was performed. The outcome of the event was reported as fatal. Health Authority Comment: Patient in apparent good health, currently do not have other details (case occurred to family member in another Region).; Reported Cause(s) of Death: stroke
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166